People who did not have insurance or were covered by government programs tended to receive head and neck cancer treatment at hospital types linked with worse survival, according to a study involving >37,000 individuals. Participants were from the Nationwide Inpatient Sample 2012 and 2013. Investigators looked at the relationship between insurance and provider types. Among the results:
- After adjusting for certain variables, Medicaid, Medicare, and uninsured patients were between 14% more likely and >twice as likely than those who were privately insured to be treated at rural, urban nonteaching, private investor–owned, or government hospitals.
- The trend remained even after adjusting for geographic location.
Gupta A, Sonis A, Schneider E, Villa A. Impact of the insurance type of head and neck cancer patients on their hospitalization utilization patterns. [Published online ahead of print November 7, 2017]. Cancer. doi:10.1002/cncr.31095.
This Week's Must Reads
Abemaciclib as Initial Therapy for Advanced BC, J Clin Oncol; 2017 Nov 10; Goetz, Toi, et al
BC Recurrence Risk Post-Endocrine Therapy Assessed, N Engl J Med; 2017 Nov 9; Pan, Gray, et al
The Value of an Embedded Palliative Care Program, Breast Cancer Res Treat; ePub 2017 Oct 30; Rabow, et al
Does Weight Gain Impact BC Disease Recurrence?, Clin Breast Cancer; ePub 2017 Nov 8; Raghavendra, et al
Abemaciclib + Fulvestrant in Advanced BC Evaluated, J Clin Oncol; 2017 Sep 1; Sledge, Toi, et al
Must Reads in Practice Management
Survival as a Quality Metric of Cancer Care, J Oncol Pract; ePub 2017 Nov 1; Shulman, et al
Prostate Ca Outcomes by Insurance Type Assessed, Cancer; ePub 2017 Oct 30; Mahal, Mahal, et al
Impact of Insurance Type on Head and Neck Cancer, Cancer; ePub 2017 Nov 7; Gupta, Sonis, et al
Care Transitions in Patients with Advanced Cancer, J Clin Oncol; ePub 2017 Oct 25; Lage, et al
Racial and Ethnic Disparities in Cancer Survival, J Clin Oncol; ePub 2017 Oct 16; Ellis, et al